Evidence of axonal damage in human acute demyelinating diseases

Journal of the Neurological Sciences
N GhoshM M Esiri

Abstract

Substantial axon damage, detected by immunostaining for beta amyloid precursor protein (betaAPP) has been demonstrated in acute demyelinating lesions in multiple sclerosis. The present study aimed to determine if this was also the case in the other human acute demyelinating diseases, acute hemorrhagic leucoencephalitis (AHLE), acute disseminated encephalomyelitis (ADEM) and central pontine myelinolysis (CPM). BetaAPP immunostaining was used as a marker of axonal damage in autopsy material from these conditions. Axonal damage was detected in all these conditions. Its extent varied within and between them. Axonal damage was largely confined to tissue adjacent to veins and venules in AHLE and ADEM but was unrelated to proximity to these vessels in CPM. Substantial axon damage occurs in fatal cases of AHLE, ADEM and CPM.

References

Feb 1, 1982·Annals of Neurology·M D NorenbergA S Robertson
Jan 1, 1994·Acta Neuropathologica·F E SherriffS Wilson
Mar 1, 1997·Brain : a Journal of Neurology·B FergusonV H Perry
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
May 5, 1999·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·A I BhigjeeP L Bill
Feb 1, 2000·Molecular Medicine Today·R GoldK V Toyka
Jun 7, 2000·Neuropathology and Applied Neurobiology·J F GeddesD I Graham
Nov 4, 2000·Journal of Child Neurology·K L HungM L Tsai
May 16, 2002·Acta Neuropathologica·G C DeLucaP Davey
Sep 24, 2002·Brain : a Journal of Neurology·Tanja KuhlmannWolfgang Brück
Feb 5, 2003·Brain : a Journal of Neurology·I M Medana, M M Esiri

❮ Previous
Next ❯

Citations

Jan 5, 2008·Acta Neuropathologica·Tanja KuhlmannWolfgang Brück
Oct 15, 2005·Nature Reviews. Neuroscience·Michael Coleman
Oct 8, 2005·BMJ : British Medical Journal·Rachel AbbottEnefiok Ekpo
Feb 9, 2012·Annual Review of Pathology·Bogdan F Gh Popescu, Claudia F Lucchinetti
Sep 18, 2014·Brain Pathology·Gabriele C DeLucaMargaret M Esiri
Jul 26, 2011·Brain & Development·Yukifumi MondenMariko-Yoshida Momoi
Feb 15, 2008·Clinical Neurology and Neurosurgery·Silvia N Tenembaum
Jun 24, 2011·Neuropathology and Applied Neurobiology·S C TauberR Nau
Mar 23, 2013·Neuropathology and Applied Neurobiology·Simone C TauberRoland Nau
Sep 15, 2005·Neuroscience Letters·Angela M WongCaleb E Finch
Feb 2, 2011·The American Journal of Pathology·John S TzartosLars Fugger
Dec 19, 2014·Brain Pathology·Gabriele C DeLucaSarah A Morrow
Jan 18, 2011·NeuroImage·Eric C KlawiterTammie L Benzinger
Oct 8, 2009·Journal of Child Neurology·Soe MarMichael Noetzel
Dec 20, 2007·Journal of Neuropathology and Experimental Neurology·Gabriele M Zu-RheinJames M Powers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.